A New Paradigm for
Treating CNS Diseases

Inhibikase is a company innovating small-molecule kinase inhibitor therapeutics targeting CNS disease, including diseases of the brain. MORE

neurodegenerative-2018-340.png
Programs focused on reversing the course of neurodegenerative diseases
hematological-2018-340.png
Programs focused on hematological and gastrointestinal cancers
brain-infection-2018-340.png
Programs focused on treating life-threatening brain infections

LATEST NEWS

April 09, 2019
Inhibikase Therapeutics Announces Appointment of Elizabeth O’Farrell to its Board of Directors

March 19, 2019
Inhibikase Therapeutics Expands its Scientific Advisory Board with the Appointment of Leading Experts in Parkinson’s Disease

HOME | SITEMAP | CONTACT | Privacy | Legal
"Inhibikase Therapeutics" is a registered trademark of Inhibikase Therapeutics, Inc. | © 2019 Inhibikase Therapeutics, Inc. All rights reserved.
Back to Top